Race Oncology Ltd (ASX:RAC, OTC:RAONF) earlier this week announced the launch of two new clinical programs for its lead drug, RC220. The company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback